Skip to main content
Clinical Trials/NCT02219152
NCT02219152UnknownPhase 2

Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

Liran Levy1 site in 1 country120 target enrollmentStarted: September 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Sponsor
Liran Levy
Enrollment
120
Locations
1
Primary Endpoint
amount of bleeding

Study Overview

Brief Summary

Bleeding during transbronchial ro endobronchial biopsy is rather a common complication.

Mostly this is an insignificant bleeding, but in 3% of the biopsies there is a substantial amount of bleeding that requires a special treatment or follow up.

The goal of this study is to examine whether submission of tranexamic acid during the biopsy could diminish the amount of bleeding.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient that are candidates to endobronchial or transcronchial biopsy

Exclusion Criteria

  • S/P MI or CVA or PE or DVT .
  • S/P thrombophilia.
  • Patients under coagulation therpay
  • Chronic Renal Failure
  • Pregnancy

Arms & Interventions

tranexamic acid

Experimental

tranexamic acid will be administrated using the bronchoscope

Intervention: tranexamic acid (Drug)

saline

Placebo Comparator

the saline will be administrated using an infusion during the biopsy.

Intervention: saline (Drug)

Outcomes

Primary Outcomes

amount of bleeding

Time Frame: participants will be followed for the duration of hospital stay, an expected average of one day

amount of bleedibg that will be calculated on the basis of the difference between the amount of saline that will be injected at the bronchoscopy and the blood and fluid that will be collected in the suction tank.

Secondary Outcomes

  • amount of erythrocytes(participants will be followed for the duration of hospital stay, an expected average of one day)

Investigators

Sponsor
Liran Levy
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Liran Levy

Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

Hadassah Medical Organization

Study Sites (1)

Loading locations...

Similar Trials

Topical Instillation of Tranexamic Aacid... | Clinical Trial